Search
Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
- blonca9
- Apr 4, 2024
- 1 min read
Bill Newell describes this week’s deal with Ipsen, the folate receptor alpha space, designing therapies with non-cell protein synthesis, and Sutro’s numerous partnerships.